India Suffer Dual Fitness Blow as Harshit Rana and Hardik Pandya...
Fast bowler Harshit Rana and all-rounder Hardik Pandya face significant fitness setbacks ahead of India's upcoming tour of New Zealand, scheduled to...
By GT24x7 Reporter··GlobalToday24x7
Fitness Setbacks Cloud Selection Ahead of India's Tour of New Zealand
The Indian cricket team faces selection complications ahead of its upcoming bilateral tour of New Zealand after medical updates confirmed setbacks for pace bowler Harshit Rana and star all-rounder Hardik Pandya. The multi-format tour, scheduled to run from October 22 to December 1, 2026, comprises five Twenty20 Internationals, five One Day Internationals, and two Test matches. Recent evaluations conducted by the Board of Control for Cricket in India (BCCI) medical staff at the Centre of Excellence (COE) in Bengaluru indicate that both players are unlikely to achieve full match fitness in time for the opening legs of the series.
The national selection committee, chaired by Ajit Agarkar, was scheduled to finalize the white-ball squad in the coming week. However, the unexpected delay in the recovery timelines of both Rana and Pandya has forced the team management to evaluate alternative pace-bowling and all-round options to maintain balance across the squad.
Delhi paceman Harshit Rana, who was undergoing a structured rehabilitation program for a thigh strain at the Centre of Excellence, experienced an unexpected interruption in his recovery regimen. According to medical reports, Rana contracted a high fever accompanied by a sore throat and cold symptoms just as he was scheduled to resume light bowling workloads. Medical specialists supervising his recovery advised a mandatory three-week restriction on strenuous physical activity until he achieves complete systemic recovery.
As a result of this health setback, Rana's return to competitive cricket has been deferred. The 24-year-old fast bowler is expected to miss the entire New Zealand tour and is instead slated to target a domestic comeback for Delhi during the Syed Mushtaq Ali Trophy scheduled for next month. The delay represents another obstacle for the young pacer, whose recent international campaign was previously curtailed by a knee injury requiring surgical intervention prior to the 2026 T20 World Cup.
All-rounder Hardik Pandya has encountered renewed discomfort in his right calf muscle, complicating his return to international cricket. Pandya, who has been sidelined from top-tier competitive action since the conclusion of the 2026 Indian Premier League season, experienced soreness following a comprehensive fitness assessment conducted on September 19. The recurring issue had previously led to his withdrawal from the India 'A' squad for the multi-match series against Australia 'A' in Puducherry.
The medical panel at the Centre of Excellence has recommended a specialized therapeutic regimen for Pandya, including bisphosphonates therapy, Vitamin D supplementation, and low-impact conditioning drills. Team doctors emphasized a phased progression, mandating that Pandya complete light resistance training before transitioning back to running and high-intensity cricket activities. Given the extended timeline required for his physical reconditioning, Pandya's inclusion in the white-ball leg of the New Zealand tour remains highly doubtful.
BCCI Medical Policy and Selection Considerations
The double fitness setback highlights the stringent load-management protocols instituted by the BCCI in 2026. Under the revised medical framework, players returning from long-term injuries must clear rigorous match-simulation assessments and domestic competitive matches before receiving clearance for national selection. The board has reiterated its policy of prioritizing long-term physical durability over rushed returns, particularly with an intensive international calendar ahead.
With Rana and Pandya temporarily sidelined, selectors are considering inclusions such as Prasidh Krishna, Yash Thakur, and Nitish Kumar Reddy to bolster the seam bowling department for the conditions expected in New Zealand.